{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:20:46Z","timestamp":1793654446478,"version":"4.5.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Sickle cell disease is a major public health problem in India. Lack of rapid and reliable diagnostic methods result in many avoidable deaths in affected population. Current diagnostic tools are laboratory based, expensive and need trained manpower. Here, we evaluated the performance of a microchip-based cellulose acetate electrophoresis test, \u201cGazelle\u201d in the tribal-dominated Indian states of Chhattisgarh and Madhya Pradesh. A total of 1,050 patients were screened by sickle cell solubility, hemoglobin (cellulose acetate) electrophoresis, high-performance liquid chromatography (HPLC) and Gazelle. Of the total 1,027 test results obtained, 960 tests were \u201cValid\u201d (93.5%) and included in the analysis. Gazelle identified all patients with disease (HbSS and Thalassemia Major) with 100% accuracy. Gazelle demonstrated 100% sensitivity when comparing sickle cell disease (SCD) vs. sickle cell trait and SCD vs. normal. Specificity was 98.9% and 99.5% when comparing SCD vs. trait and trait vs. normal, respectively. Specificity was 99.8% when comparing SCD vs. normal and sensitivity was 99.3% when comparing trait vs. normal. Overall, Gazelle yielded a high accuracy (99.0%) compared to reference standard tests (hemoglobin electrophoresis and HPLC). Gazelle is a low-cost, rapid diagnostic test with high accuracy for detecting SCD both quantitatively and qualitatively. Gazelle can be a potential screening tool for the rapid diagnosis in resource limited settings and developing countries with high burden of hemoglobin disorders.<\/jats:p>","DOI":"10.3389\/fmed.2021.639208","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:05:01Z","timestamp":1634087101000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of Microchip-Based Point-Of-Care Device \u201cGazelle\u201d for Diagnosis of Sickle Cell Disease in India"],"prefix":"10.3389","volume":"8","author":[{"given":"Shweta","family":"Shrivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Gwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramswaroop","family":"Uikey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Kant","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyaleela","family":"Thota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparup","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kumar","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasubramaniam","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1590\/s0042-96862001000800005","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull World Health Organ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/ijmr.IJMR","article-title":"Sickle cell disease: progress made & challenges ahead","volume":"151","author":"Odame","year":"2020","journal-title":"Indian J Med Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.hoc.2015.11.005","article-title":"Sickle cell disease in Sub-Saharan Africa","volume":"30","author":"Williams","year":"2016","journal-title":"Hematol Oncol Clin North Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MOH.0000000000000029","article-title":"Sickle cell disease in India","volume":"21","author":"Colah","year":"2014","journal-title":"Curr Opin Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/03630269.2014.931287","article-title":"Prevalence of the beta(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India","volume":"38","author":"Shrikhande","year":"2014","journal-title":"Hemoglobin."},{"key":"B8","first-page":"288","article-title":"Morbidity pattern of sickle cell disease in India: a single centre perspective","volume":"138","author":"Tewari","year":"2013","journal-title":"Indian J Med Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4103\/0971-5916.159492","article-title":"Sickle cell disease in tribal populations in India","volume":"141","author":"Colah","year":"2015","journal-title":"Indian J Med Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/tropicalmed4040125","article-title":"Attrition from care and clinical outcomes in a cohort of sickle cell disease patients in a tribal area of Western India","volume":"4","author":"Dave","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"193252","DOI":"10.1155\/2013\/193252","article-title":"Sickle cell disease: new opportunities and challenges in Africa","volume":"2013","author":"Makani","year":"2013","journal-title":"ScientificWorldJournal."},{"key":"B15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1039\/C9AN02250C","article-title":"Paper-based microchip electrophoresis for point-of-care hemoglobin testing","volume":"145","author":"Hasan","year":"2020","journal-title":"Analyst."},{"key":"B17","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ."},{"key":"B18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/labmed\/6.4.38","article-title":"A solubility test for sickle cell-hemoglobin","volume":"6","author":"Diggs","year":"1975","journal-title":"Lab Med."},{"key":"B19","volume-title":"Laboratory Haematology: An Account Of Laboratory Techniques","author":"Chanarin","year":"1989"},{"key":"B20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bcmd.2017.08.010","article-title":"The pressing need for point-of-care diagnostics for sickle cell disease: a review of current and future technologies","volume":"67","author":"McGann","year":"2017","journal-title":"Blood Cells Mol Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.639208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:05:05Z","timestamp":1634087105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.639208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":20,"alternative-id":["10.3389\/fmed.2021.639208"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.639208","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"article-number":"639208"}}